Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.

el-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, et al.

Cancer Res. 1995 Jul 1;55(13):2910-9.

3.

p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells.

Cereseto A, Diella F, Mulloy JC, Cara A, Michieli P, Grassmann R, Franchini G, Klotman ME.

Blood. 1996 Sep 1;88(5):1551-60.

5.

Expression of p21WAF1/CIP1 in fetal and adult tissues: simultaneous analysis with Ki67 and p53.

Mateo MS, Saez AI, Sanchez-Beato M, Garcia P, Sanchez-Verde L, Martinez JC, Orradre JL, Piris MA.

J Clin Pathol. 1997 Aug;50(8):645-53.

6.

Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells.

Wu Q, Kirschmeier P, Hockenberry T, Yang TY, Brassard DL, Wang L, McClanahan T, Black S, Rizzi G, Musco ML, Mirza A, Liu S.

J Biol Chem. 2002 Sep 27;277(39):36329-37. Epub 2002 Jul 22.

9.

Alternative pathway of transcriptional induction of p21WAF1/Cip1 by cyclosporine A in p53-deficient human glioblastoma cells.

Zupanska A, Adach A, Dziembowska M, Kaminska B.

Cell Signal. 2007 Jun;19(6):1268-78. Epub 2007 Jan 20.

PMID:
17321721
10.

p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations.

Viale G, Pellegrini C, Mazzarol G, Maisonneuve P, Silverman ML, Bosari S.

J Pathol. 1999 Feb;187(3):302-7.

PMID:
10398083
11.
12.

Selective loss of endogenous p21waf1/cip1 induction underlies the G1 checkpoint defect of monomeric p53 proteins.

Tarunina M, Grimaldi M, Ruaro E, Pavlenko M, Schneider C, Jenkins JR.

Oncogene. 1996 Aug 1;13(3):589-98.

PMID:
8760300
13.
14.
15.

Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway.

Liu Y, Martindale JL, Gorospe M, Holbrook NJ.

Cancer Res. 1996 Jan 1;56(1):31-5.

16.

The role of p53, p21WAF1/C1PI, and bcl-2 in radioresistant colorectal carcinoma.

Palazzo JP, Kafka NJ, Grasso L, Chakrani F, Hanau C, Cuesta KH, Mercer WE.

Hum Pathol. 1997 Oct;28(10):1189-95.

PMID:
9343326
17.

p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.

Kagawa S, Fujiwara T, Hizuta A, Yasuda T, Zhang WW, Roth JA, Tanaka N.

Oncogene. 1997 Oct 16;15(16):1903-9.

18.

Posttranscriptional regulation of p21WAF1/CIP1 expression in human breast carcinoma cells.

Li XS, Rishi AK, Shao ZM, Dawson MI, Jong L, Shroot B, Reichert U, Ordonez J, Fontana JA.

Cancer Res. 1996 Nov 1;56(21):5055-62.

19.

UV-B/A irradiation of mouse keratinocytes results in p53-mediated WAF1/CIP1 expression.

Liu M, Pelling JC.

Oncogene. 1995 May 18;10(10):1955-60.

PMID:
7761096
20.

Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells.

Lee SJ, Ha MJ, Lee J, Nguyen P, Choi YH, Pirnia F, Kang WK, Wang XF, Kim SJ, Trepel JB.

J Biol Chem. 1998 Apr 24;273(17):10618-23.

Supplemental Content

Support Center